4. DEVELOPMENTAL ANATOMY(CONT..)
• otic vesicle, otocyst
• The semicircular
canals, utricle, saccule,
and cochlea - are
fashioned by modelling
of the otic vesicle.
5. DEVELOPMENTAL ANATOMY(CONT..)
• otic capsule
• This cartilaginous
envelope which
surrounds the
nervous elements
of the embryo's
inner ear
subsequently
ossifies to form
bony labyrinth
8. Definition of otosclerosis /
otospongiosis:
• Otosclerosis is a genetically-mediated
primary metabolic bone disease of the otic
capsule in which the normal dense
enchondral layer of otic capsule is replaced by
irregularly laid focus/foci of spongy bone
• Fixation of the ossicle
• conductive or mixed hearing loss
9.
10. ETIOLOGY
• Exact cause not known.
• Heredity: Family history of deafness is present in 50% of
cases.
• Sex: females are affected twice as often as males.
• Age of onset: usually occurs between 20-30 years of age.
• Pregnancy: Otosclerosis may be initiated or aggravated by
pregnancy but never caused by it.
11.
12. • Viral.
– Electron micro: viral nucleocapsids in cells of
otospongiotic lesions
– Immunohistochemical: measles virus
nucleocapsid protein in cells associated with
otospongiosis.(McKenna 1986)
– Polymerase chain reaction (PCR) : anti-measles
IgG in the perilymph of patients with otosclerosis
13.
14. Most common sites of
involvement
• Anterior oval window niche / fissula ante
fenestrum (80-90%)
15. OTHER AREAS
• Round window niche (30-50%)
• Apical medial wall of the cochlea
• Posterior to the oval window
• Posterior internal auditory canal
• Primary footplate
• Semicircular canals
16. Pathophysiology
Normal bone is absorbed and replaced by vascular spongy osteoid
tissue
Bone become thicker and less vascular
Fixes the stapes
Prevents vibration of ear bones in response to sound waves
Conductive deafness
Spread to foot plates of stapes
Affect bony capsule of the labyrinth
Results in sensory neural deafness
22. 1.Early or spongiotic phase
(otospongiosis)
Osteolytic resorption of bone
develops a spongy appearance. It
causes vascular dilation bone surrounding
blood vessels.
“Schwartze's sign”.
28. Epidemiology
• Gender
– Histologic otosclerosis – 1:1 ratio
– Clinical otosclerosis – 2:1 (W:M)
• Age
– 15-45 yrs most common age range of presentation
30. History
• Most common presentation
– Women age 20 - 30
– Conductive or Mixed hearing loss
• Slowly progressive,
• Bilateral (80%)
• Asymmetric
31. History
– Tinnitus (75%) – cochlear / active
– ParacusisWillisi- better hearing in noisy
environment
– Speech : monotonous, soft
Family history
2/3 have a significant family history
Particularly helpful in patients with severe or profound
mixed hearing loss
32. History
History of ear infections
Vestibular symptoms
25%
Most commonly dysequilibrium
Occasionally attacks of vertigo with rotatory
nystagmus
33. Physical Exam
OTOSCOPY
Most helpful in ruling out other disorders
Middle ear effusions
Tympanosclerosis
Tympanic membrane perforations
Cholesteatoma or retraction pockets
Superior semicircular canal dehiscence
43. Type A represents normal middle ear function. Type
A curves have normal mobility and pressures and
typify normal hearing and sensorineural hearing loss
with normally functioning middle ear systems.
44. Type As represents normal middle ear pressure but
reduced mobility suggesting limited mobility of the
tympanic membrane and middle ear structure,
commonly seen in fixation of the ossicular chain.
45.
46.
47. Imaging
Computed tomography (CT) of the temporal
bone
Proponents of CT for evaluation of otosclerosis
Pre-op
Characterize the extent of otosclerosis
Severe or profound mixed hearing loss
Evaluate for enlarge cochlear aqueduct
Post-op
Recurrent CHL
Re-obliteration vs. prosthesis dislocation
Vertigo
48.
49.
50. a transverse CT-image
showing a subtle
otosclerotic focus in
the characteristic site:
the fissula ante
fenestram (arrows).
51. There is a lucency
anterior to the oval
window (arrow) and
between the cochlea
and the internal
auditory canal.
This is combined
fenestral and
retrofenestral
otosclerosis
53. • a patient with a
well-positioned
metallic
stapedial
prosthesis:
medially it
touches the oval
window and
laterally it
connects with
the long process
of the incus.
Notice the lucency between vestibule and
cochlea as a manifestation of otosclerosis
(arrow).
55. Medical
• SODIUM FLUORIDE
– Mechanism
– Fluoride ion replaces hydroxyl group in bone
forming fluorapatite
– solid solution with hydroxylapatite [Ca5(PO4)3OH]
in biological matrices >> hard crystalline solid
[Ca5(PO4)3F ]
– Resistant to resorption
– Increases calcification of new bone
– Causes maturation of active foci of otosclerosis
56. Medical
SODIUM FLUORIDE
Reduces tinnitus, reverses Schwartze’s sign, resolution of
otospongiosis seen on CT
Dose – 20-120mg
Indications
Non-surgical candidates
Patients who do not want surgery
Surgical candidates with + Schwartze’s sign
Treat for 6 months pre-operatively
Post-op. if otospongiosis detected intra-op.
57. Medical
SODIUM FLUORIDE
Hearing results
50% stabilize
30% improve
Re-evaluate q 2 yrs with CT and for Schwartze’s
sign to resolve
If fluoride are stopped – expect re-activation
within 2-3 years
59. Medical
BISPHOSPHONATES
Class of medications that inhibits bone resorption by
inhibiting osteoclastic activity
Studies conducted on otosclerosis patients with
neurotologic symptoms report the majority of
patients with subjective improvement or resolution.
Future application of this treatment unclear, especially
with new reports of bisphosphonate related
osteonecrosis.
60. HEARING AID
Indication:
- Non-surgical candidates
- Patients who do not desire surgery
- Following improvement of CHL
- Patients with conductive and sensorineural
hearing loss greater than 25db.
61. BAHA
Indicated for conductive and mixed hearing
loss as well as for single sided deafness.
Only hearing ear with otosclerosis combined
with difficulty using a conventional aid, or a
post – fenestration cavity.
62.
63. Surgery
Best surgical candidate
Previously un-operated ear
Good health
UnacceptableAir-Bone Gap
25 to 40 dB
Negative Rinne test
Excellent speech discrimination (>60%)
Desire for surgery
64. Surgery
Poor factors for surgery
Age of the patient
Elderly(>70yrs) & general medical diseases
Poorer results in the high frequencies
Congenital stapes fixation (44% success rate)
Juvenile otosclerosis (82% success rate)
Occupation
Divers / Pilots / Airline steward/stewardess
65. Surgery
• Other factors
– Vestibular symptoms
• Meniere's disease
– Concomitant otologic disease
• Cholesteatoma
• Tympanic membrane perforation /CSOM /ASOM
– Positive schwartze sign (active focus/cochlear
otosclerosis)
– Only hearing ear
– Poor ET function
66.
67.
68. Canal Injection
2-3 cc of 1% lidocaine
with 1:50,000 or
1:100,000 epinephrine
4 quadrants
Bony cartilaginous
junction
69. Raise Tympanomeatal Flap
6 and 12 o’clock
positions
6-8 mm lateral to the
annulus
Take into account
curettage of the
scutum
70.
71.
72.
73.
74.
75.
76.
77.
78.
79.
80.
81.
82.
83.
84.
85.
86.
87.
88. First laser stapedotomy performed by Perkins
in 1978
Less trauma to the vestibule
Less incidence of prosthesis migration
Less fixation of prosthesis by scar tissue
89. Drill Fenestration
0.7mm diamond burr
Motion of the burr
removes bone dust
Avoids smoke
production
Avoids surrounding heat
production
90. Laser Fenestration
Laser
Avoids manipulation of the footplate
Argon and Potassium titanyl phosphate (KTP/532)
Wave length 500 nm
Visible light
Absorbed by hemoglobin
Surgical and aiming beam
Carbon dioxide (CO2)
10,000 nm
Not in visible light range
Surgical beam only
Requires separate laser for an aiming beam (red helium-neon)
Ill defined fuzzy beam
105. Overhanging Facial Nerve
Usually dehiscent
Consider aborting the procedure
Facial nerve displacement (Perkins, 2001)
Facial nerve is compressed superiorly with No. 24
suction (5 second periods)
10-15 sec delay between compressions
Perkins describes laser stapedotomy while nerve is
compressed
Wire piston used
Add 0.5 to 0.75 mm to accommodate curve around the
nerve
106.
107. Floating Footplate
Footplate dislodges from the surrounding
OW niche
Incidental finding
More commonly iatrogenic
Prevention
Laser
Footplate control hole
Management
Abort
H. House favors promontory fenestration and
total stapedectomy
Perkins favors laser fenestration
108. Diffuse Obliterative
Otosclerosis
Occurs when the
footplate, annular
ligament, and oval
window niche are
involved
Closure of air-bone gap
< 10 dB less common.
Refixation commonly
occurs
109. Perilymphatic Gusher
Associated with patent cochlear aqueduct
More common on the left
Increased incidence with congenital stapes
fixation
Increases risk of SNHL
Management
Rough up the footplate
Rapid placement of the OW seal then the prosthesis
HOB elevated, stool softeners, bed rest, avoid
Valsalva, +/- lumbar drain
110. Round Window Closure
20%-50% of cases
1% completely
closed
No effect on
hearing unless
100% closed
Opening has a
high rate of SNHL
118. Reparative Granuloma
• Granuloma formation around the prosthesis and
incus
• 2 -3 weeks postop
• Initial good hearing results followed by an increase in
the high frequency bone line thresholds
• Associated tinnitus and vertigo
• Exam – reddish discoloration of the posteriorTM
• Treatment
– ME exploration
– Removal of granuloma
• Prognosis – return of hearing with early excision
• Associated with use of Gelfoam
119. Vertigo
Most commonly short lived (2-3 days)
More prolonged after stapedectomy
compared to stapedotomy
Due to serous labyrinthitis
Medialization of the prosthesis into the
vestibule
With or without perilymphatic fistula
Reparative granuloma
120. Recurrent Conductive Hearing
Loss
Slippage or displacement of the prosthesis
Most common cause of failure
Immediate
Technique /Trauma
Delayed
Slippage from incus narrowing or erosion
Adherence to edge of OW niche
Stapes re-fixation
Progression of disease with re-obliteration of OW
Malleus or incus ankylosis
SAY:Before we wrap up the course, let’s review what we have learned today.
During this course, we have
<READ the bullets from the slide.>
GO to next slide.